Has Marina Osborn received payments from drug or device companies?

Yes. Drug and device makers reported $3,716 in general payments to Marina Osborn across 224 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marina Osborn did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marina Osborn come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marina Osborn

Family · Seneca, SCNPI 1538896964

Payments from drug & device makers

$3,716in general payments, 2019–2025

Across 224 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$515
Supernus Pharmaceuticals, Inc.$427
Takeda Pharmaceuticals U.S.A., Inc.$291
Axsome Therapeutics, Inc.$274
Alkermes, Inc.$250
AbbVie$245
plus $2K from 16 others

What the payments were for

Food & beverage$3,716100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	38	$515
Supernus Pharmaceuticals, Inc.	19	$427
Takeda Pharmaceuticals U.S.A., Inc.	21	$291
Axsome Therapeutics, Inc.	12	$274
Alkermes, Inc.	12	$250
AbbVie	21	$245
Corium, LLC	20	$240
Teva Pharmaceuticals USA, Inc.	13	$231
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	13	$204
Ironshore Pharmaceuticals Inc.	8	$185
Tris Pharma Inc	8	$166
Johnson & Johnson	7	$145
Vanda Pharmaceuticals Inc.	5	$138
Neurocrine Biosciences, Inc.	6	$102
Lundbeck LLC	5	$72
Bausch Health US, LLC	4	$56
Avanir Pharmaceuticals, Inc.	3	$39
Noven Therapeutics, LLC	2	$35
Idorsia Pharmaceuticals US Inc	2	$32
Sunovion Pharmaceuticals Inc.	3	$32
Almatica Pharma LLC	1	$20
Neos Therapeutics, LP	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

QELBREE$125
Auvelity$118

How this compares

$3,716 in reported general payments places this provider in the 85th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Bupropion XlBupropion Hcl	32	$203
Quetiapine Fumarate	11	$201
Oxcarbazepine	14	$194
Buspirone Hcl	20	$188
Duloxetine Hcl	17	$151
Aripiprazole	14	$141
Lamotrigine	20	$133
Gabapentin	19	$128
Venlafaxine Hcl ErVenlafaxine Hcl	12	$122
Baclofen	14	$95
Diazepam	27	$84
Alprazolam	13	$65
Fluoxetine Hcl	22	$57
Mirtazapine	13	$15

Paid to pharmacies, not to this prescriber.

Other family in Seneca

Kristine BoswellSeneca$17K
Alison FogartyGreenville$2M
Sara ChristieGreenville$229K
Kara Cooper GilmerAnderson$127K
Jessica BellEasley$96K
Carrie HendersonGreenville$91K
Sarah ValerioGreer$76K
Mary WilliamsColumbia$67K
Michelle StrongGreenville$55K
Karen McKerihanSummerville$54K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →